-
Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
CNS drugs 20130901
-
State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
Psychiatry and clinical neurosciences 20120601
-
Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
Psychiatry and clinical neurosciences 20120401
-
Pharmacokinetics and metabolism update for some recent antipsychotics.
Expert opinion on drug metabolism & toxicology 20110701
-
Mirtazapine in combination with perospirone synergistically enhances dopamine release in the rat prefrontal cortex via 5-HT1A receptor activation.
Psychiatry and clinical neurosciences 20110401
-
A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone.
Progress in neuro-psychopharmacology & biological psychiatry 20110115
-
An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 20110115
-
The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients.
Progress in neuro-psychopharmacology & biological psychiatry 20100816
-
Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.
Psychopharmacology 20100501
-
Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients.
Human psychopharmacology 20100401
-
Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
Psychiatry research 20090630
-
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Psychiatry and clinical neurosciences 20090601
-
Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 20090430
-
Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Die Pharmazie 20080801
-
Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells.
European journal of clinical pharmacology 20080701
-
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080601
-
[Usefulness of perospirone for the prevention of nausea related to opioid administration].
Gan to kagaku ryoho. Cancer & chemotherapy 20080401
-
Long-term perospirone treatment with a single dose at bedtime in schizophrenia: relevant to intermittent dopamine D2 receptor antagonism.
Progress in neuro-psychopharmacology & biological psychiatry 20080215
-
The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma.
Progress in neuro-psychopharmacology & biological psychiatry 20080101
-
Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 20070509
-
Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
-
A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
Psychopharmacology 20070501
-
Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Progress in neuro-psychopharmacology & biological psychiatry 20070330
-
Determination of perospirone by liquid chromatography/electrospray mass spectrometry: application to a pharmacokinetic study in healthy Chinese volunteers.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301
-
Alteration in serum neural cell adhesion molecule in patients of schizophrenia.
Human psychopharmacology 20070301
-
Perospirone in the treatment of patients with delirium.
Psychiatry and clinical neurosciences 20070201
-
Perospirone in treatment of Huntington's disease: a first case report.
Progress in neuro-psychopharmacology & biological psychiatry 20070130
-
New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone.
Internal medicine (Tokyo, Japan) 20070101
-
[Pharmacokinetics of perospirone hydrochloride at an excessive dose and changes in the serum prolactin level].
Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20070101
-
5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.
Clinical and experimental pharmacology & physiology 20070101
-
Neuroleptic malignant syndrome induced by perospirone.
The international journal of neuropsychopharmacology 20061001
-
Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
Journal of clinical psychopharmacology 20061001
-
Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite.
Progress in neuro-psychopharmacology & biological psychiatry 20060930
-
The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
Progress in neuro-psychopharmacology & biological psychiatry 20060830
-
Efficacy of perospirone in the management of aggressive behavior associated with dementia.
Progress in neuro-psychopharmacology & biological psychiatry 20060601
-
Effective treatment of coprophagia in a patient with schizophrenia with the novel atypical antipsychotic drug perospirone.
Pharmacopsychiatry 20060501
-
Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
Progress in neuro-psychopharmacology & biological psychiatry 20060301
-
Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
The American journal of psychiatry 20060301
-
Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone.
Therapeutic drug monitoring 20060201
-
Beneficial effects of perospirone on aggressive behavior associated with dementia.
Psychiatry and clinical neurosciences 20060201
-
Perospirone for treatment of dissociative identity disorder.
Psychiatry and clinical neurosciences 20051001
-
Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.
Journal of pharmacological sciences 20051001
-
Perospirone improves food refusal in elderly patients with mental disorders.
Journal of clinical psychopharmacology 20050601
-
Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050501
-
Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Biopharmaceutics & drug disposition 20050301
-
Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
Progress in neuro-psychopharmacology & biological psychiatry 20050201
-
Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia.
Clinical neuropharmacology 20050101
-
A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.
Psychopharmacology 20041101
-
Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
The Journal of clinical psychiatry 20041101
-
Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex.
Neuroscience letters 20040812
-
Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response.
Therapeutic drug monitoring 20040801
-
Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex.
Neuroscience letters 20040624
-
Two cases of perospirone-induced mania in schizophrenia.
The Journal of clinical psychiatry 20040101
-
Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
International clinical psychopharmacology 20040101
-
Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.
Neuro endocrinology letters 20040101
-
[Treatment of 'the premonitory state of schizophrenia' with atypical antipsychotics].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101
-
Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor.
Journal of pharmacological sciences 20030901
-
Determination of a new atypical antipsychotic agent perospirone and its metabolite in human plasma by automated column-switching high-performance liquid chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030615
-
Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone.
Journal of pharmacological sciences 20030301
-
[An introduction to antipsychotics].
Ryoikibetsu shokogun shirizu 20030101
-
[Extrapyramidal syndrome].
Ryoikibetsu shokogun shirizu 20030101
-
In vitro metabolism of perospirone in rat, monkey and human liver microsomes.
European journal of drug metabolism and pharmacokinetics 20030101
-
In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes.
European journal of drug metabolism and pharmacokinetics 20030101
-
Distribution of perospirone to melanin in pigmented rats.
European journal of drug metabolism and pharmacokinetics 20030101
-
[Perospirone therapy in elderly patients with schizophrenia].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20030101
-
Perospirone (Sumitomo Pharmaceuticals).
Current opinion in investigational drugs (London, England : 2000) 20020101
-
Perospirone.
CNS drugs 20010101
-
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Molecular psychiatry 19980301
-
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
European journal of pharmacology 19920410
-
Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
Japanese journal of pharmacology 19900701
-
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
Proceedings of the National Academy of Sciences of the United States of America 19751101
